Literature DB >> 1373164

An autoimmuno-dominant thyroglobulin epitope characterized by a monoclonal antibody.

E Schulz1, G Benker, H Bethäuser, L Stempka, M Hüfner.   

Abstract

It has become evident in recent years that autoimmune thyroglobulin (Tg) antibodies of Graves disease and Hashimoto's thyroiditis show a restricted epitope repertoire compared to Tg heteroantibodies. We have produced monoclonal antibodies (Mab) against human Tg by the hybridoma technique and the epitope specificity was determined by crossblocking experiments. Six noncrossreactive Mabs were used in a double determinant IRMA system for plasma Tg measurements. Sensitivity of the assays was between 1 and 2 ng/ml, intraassay variation less than 5%. Recovery experiments with added Tg were performed in 25 Graves sera with elevated Tg autoantibodies. Monoclonal antibody Tg13 showed an unusual strong interference with autoantibodies resulting in a very low recovery in all sera (median: less than 10%). In further studies Tg was digested by trypsin and after Western blotting, the resulting fragments were incubated with different Mab antibodies, a polyclonal antibody and 10 different Graves sera with high Tg autoantibodies. In contrast to all other mabs only Mab Tg13 showed several low molecular weight bands between 17 and 50 KD. The major bands recognized by Mab Tg13 corresponded to bands obtained by the autoimmune sera, which showed a very homogeneous band pattern. We conclude that Mab Tg13 is specific for an autoimmunodominant B cell epitope of human Tg.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373164     DOI: 10.1007/BF03348649

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  16 in total

1.  Human autoantibodies to thyroglobulin are directed towards a restricted number of human specific epitopes.

Authors:  C T Chan; P G Byfield; R L Himsworth; P Shepherd
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

2.  Significance of the recognition of certain antigenic regions on the human thyroglobulin molecule by natural autoantibodies from healthy subjects.

Authors:  M Bouanani; M Piechaczyk; B Pau; M Bastide
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

3.  Thyroglobulin and thyroid peroxidase share common epitopes recognized by autoantibodies in patients with chronic autoimmune thyroiditis.

Authors:  Y Kohno; N Naito; Y Hiyama; N Shimojo; N Suzuki; O Tarutani; H Niimi; H Nakajima; T Hosoya
Journal:  J Clin Endocrinol Metab       Date:  1988-11       Impact factor: 5.958

4.  The immunoreaction of auto- and heteroantisera with modified human thyroglobulin.

Authors:  G B Salabè; C Davoli; S Fontana
Journal:  Int Arch Allergy Appl Immunol       Date:  1973

5.  Splitting of human thyroglobulin. II. Enzymatic digestion.

Authors:  W A Stylos; N R Rose
Journal:  Clin Exp Immunol       Date:  1969-09       Impact factor: 4.330

6.  Experimental autoimmune thyroiditis induced by a 5-10-kDa tryptic fragment from porcine thyroglobulin.

Authors:  J Salamero; J J Remy; M Michel-Bechet; J Charreire
Journal:  Eur J Immunol       Date:  1987-06       Impact factor: 5.532

7.  Human thyroglobulin autoantibodies of subclasses IgG2 and IgG4 bind to different epitopes on thyroglobulin.

Authors:  N Fukuma; S M McLachlan; V B Petersen; P Kau; J Bradbury; M Devey; K Bleasdale; P Grabowski; B R Smith
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

8.  Restrictions in the response to autologous thyroglobulin in the human.

Authors:  L Nye; L C Pontes de Carvalho; I M Roitt
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

9.  Selective autoimmune response to the chicken-specific structures of thyroglobulin in Obese strain chickens.

Authors:  C T Chan; P G Byfield; B R Champion; R L Himsworth
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

10.  Specificity of monoclonal antibodies against human thyroglobulin; comparison with autoimmune antibodies.

Authors:  J Ruf; P Carayon; N Sarles-Philip; F Kourilsky; S Lissitzky
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  3 in total

1.  Tryptic peptides of human thyroglobulin: I. Immunoreactivity with murine monoclonal antibodies.

Authors:  A M Saboori; C L Burek; N R Rose; H S Bresler; M Talor; R C Kuppers
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

2.  Tryptic peptides of human thyroglobulin: II. Immunoreactivity with sera from patients with thyroid diseases.

Authors:  A M Saboori; P Caturegli; N R Rose; S Mariotti; A Pinchera; C L Burek
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

3.  Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeys.

Authors:  Mario Losen; Aran F Labrijn; Vivianne H van Kranen-Mastenbroek; Maarten L Janmaat; Krista G Haanstra; Frank J Beurskens; Tom Vink; Margreet Jonker; Bert A 't Hart; Marina Mané-Damas; Peter C Molenaar; Pilar Martinez-Martinez; Eline van der Esch; Janine Schuurman; Marc H de Baets; Paul W H I Parren
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.